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Abstract 
Freeze-drying is a dehydration method suitable for the stabilization of heat-
labile pharmaceutical products, such as vaccines. Due to the vial-to-vial 
variability of heat and mass transfer during the process, the value of the 
critical process parameters (e.g., product temperature, sublimation rate) may 
be different between vials and batches often present significant product quality 
heterogeneity. The aim of this work was the development of a dynamic, multi-
vial mathematical model making it possible to predict risk of failure of the 
process, defined as the percentage of vials potentially rejected by quality 
inspection. This tool could assist the design of freeze-drying cycle. 
Keywords: lyophilization; vaccines; heat and mass transfer; mathematical 
modeling; design space 
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1. Introduction 
Freeze-drying is a discontinuous process used to dry heat sensitive products by means of 
sublimation of the previously frozen product (primary drying), followed by desorption of the 
unfrozen water (secondary drying). Due to the use of low temperature, freeze-drying process 
is often the only solution to produce pharmaceutical and biological products (e.g., vaccines) 
with acceptable characteristics of stability, shelf-life, and potency. During the process design, 
two main constraints need to be taken into account in order to guarantee acceptable quality 
attributes of the final product, such as the visual aspect of the freeze-dried cake and the 
moisture content. Firstly, the product temperature has to be maintained below a critical value 
(namely collapse temperature) during the sublimation and desorption steps, to avoid the loss 
of the porous product structure. Furthermore, the desorption step should be carried out long 
enough to reach the target value of residual moisture content in the final product. However, 
due to the vial-to-vial variability of heat and mass transfer, the value of the critical process 
parameters (e.g., product temperature, sublimation rate and desorption rate) may be different 
between vials and the process can often result in vial batches presenting a significant 
heterogeneity in the product quality. Several mathematical models [1-5] were developed for 
the design of the primary drying and secondary drying steps. Most of these models were 
based on average values of the model parameters (e.g., product resistance, vial heat transfer 
coefficient, characteristic desorption time) over the vial batch and only few of them took into 
account the variability of the model parameters [2, 3] due to differences in heat and mass 
mechanisms between vials processed in the same or different batches. The understanding and 
quantification of the mechanisms responsible for product quality variability can lead to a 
better prediction of the process parameters distribution and consequently of the risk of failure 
associated to the process.  
Our goal in the present study was to develop a multi-vial dynamic mathematical model for 
freeze-drying for the process design, taking into account sources responsible for heat and 
mass transfer variability among vials. The developed model was then used to propose a new 
quality risk-based approach for the design of the primary and secondary drying steps of the 
freeze-drying process, which includes the evaluation of the percentage of vials potentially 
rejected for specific combinations of operating variables.  
 
2. Theory 
2.1. Mathematical model 
The heat flux received during the process by the vial is assumed to mainly serve for the ice 
sublimation during primary drying and for the water desorption in secondary drying, the 
difference being responsible for temperature variation of product and vial in transient 
regimes. The evolution of product temperature 𝑇𝑇𝑝𝑝 (assumed to be the same as the vial) during 
primary and secondary drying can be determined as: 
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𝐶𝐶𝑝𝑝
𝑑𝑑𝑇𝑇𝑝𝑝
𝑑𝑑𝑑𝑑
= ?̇?𝑄𝑆𝑆𝑆𝑆 − ∆𝐻𝐻𝑠𝑠𝑠𝑠𝑠𝑠?̇?𝑚𝑠𝑠𝑠𝑠𝑠𝑠 − ∆𝐻𝐻𝑑𝑑𝑑𝑑𝑠𝑠?̇?𝑚𝑑𝑑𝑑𝑑𝑠𝑠   (1) 
 
Heat transfer during primary drying 
The heat transfer between the shelf and the vial ?̇?𝑄𝑆𝑆𝑆𝑆 depends on the temperature difference 
between the shelf ( 𝑇𝑇𝑆𝑆) and the product (𝑇𝑇𝑝𝑝), and can be expressed in term of vial heat transfer 
coefficient 𝐾𝐾𝑆𝑆:  
?̇?𝑄𝑆𝑆𝑆𝑆 = � 1𝐾𝐾𝑉𝑉 + 𝑙𝑙𝐼𝐼(𝑑𝑑)𝜆𝜆𝑖𝑖𝑖𝑖𝑖𝑖�−1 𝐴𝐴𝐵𝐵𝑆𝑆(𝑇𝑇𝑆𝑆 − 𝑇𝑇𝑝𝑝)   (2) 
 
The term 𝐾𝐾𝑆𝑆 depends on the vial bottom dimensions (vial–shelf contact area 𝐴𝐴𝑐𝑐 and depth of 
bottom curvature 𝑙𝑙𝐵𝐵𝑆𝑆) and the chamber pressure 𝑃𝑃𝐶𝐶  and can be defined as:[6]  
𝐾𝐾𝑆𝑆 = 𝐶𝐶1𝐴𝐴𝑐𝑐 + 𝐾𝐾𝑟𝑟 + 𝐶𝐶2𝑃𝑃𝐶𝐶
1+𝐶𝐶2
𝑙𝑙𝐵𝐵𝑉𝑉
𝜆𝜆𝑣𝑣
𝑃𝑃𝐶𝐶
     (3) 
 
𝐾𝐾𝑟𝑟  being the radiation contribution of the top and bottom shelf.[6] 
 
Mass transfer during primary drying 
During primary drying the sublimation flux can be defined by the difference between the 
equilibrium pressure at the ice-vapour interface 𝑃𝑃𝑣𝑣𝑖𝑖 and the partial vapour pressure in the 
chamber 𝑃𝑃𝑣𝑣𝐶𝐶: 
?̇?𝑚𝑠𝑠𝑠𝑠𝑠𝑠 = 𝐴𝐴𝑖𝑖𝑅𝑅𝑝𝑝 (𝑃𝑃𝑣𝑣𝑖𝑖  − 𝑃𝑃𝑣𝑣𝐶𝐶)     (4) 
 
where 𝑅𝑅𝑝𝑝 is the the mass transfer resistance of the dried layer, which depends linearly on the 
dried layer thickness for the considered product:[7] 
 
𝑅𝑅𝑝𝑝 = 𝑅𝑅𝑝𝑝0 + 𝑙𝑙𝑑𝑑𝑅𝑅𝑝𝑝1     (5) 
 
𝑃𝑃𝑣𝑣𝑖𝑖 can be calculated from the Clausius Clapeyron equation from the sublimation interface 
temperature,[6] and 𝑃𝑃𝑣𝑣𝐶𝐶 is defined as in Trelea et al.[8] assuming ideal gas law for water 
vapour in the drying chamber:  
 
𝑑𝑑𝑃𝑃𝑣𝑣𝐶𝐶
𝑑𝑑𝑑𝑑
= 𝑅𝑅𝑔𝑔 𝑇𝑇𝐶𝐶
𝑆𝑆𝐶𝐶 𝑀𝑀𝑊𝑊 (∑ (?̇?𝑚𝑠𝑠𝑠𝑠𝑠𝑠 + ?̇?𝑚𝑑𝑑𝑑𝑑𝑠𝑠) − ?̇?𝑚𝐶𝐶𝐶𝐶)𝐶𝐶𝑉𝑉1     (6) 
 
Finally, the fraction of ice 𝑓𝑓 contained in the product evolves with time as a function of the 
sublimation rate ?̇?𝑚𝑠𝑠𝑠𝑠𝑠𝑠 as: 
𝑚𝑚0
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
= −?̇?𝑚𝑠𝑠𝑠𝑠𝑠𝑠      (7) 
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 Mass transfer during secondary drying 
The multilayer model developed by Trelea et al.[9] was used to describe the desorption 
kinetics in secondary drying.  
2.2. Heat and mass transfer variability in freeze-drying 
Four sources of inter-vial product quality variability were considered in this study:  
 Vial geometry: 𝐾𝐾𝑆𝑆 is influenced by the shelf-vial contact area 𝐴𝐴𝑐𝑐 and the depth of bottom 
curvature 𝑙𝑙𝐵𝐵𝑆𝑆 (Equation 3). Thus, differences in these dimensions among the vials can results 
in variability of the heat transfer among the vials on the shelf. In the present study, the 
distributions of 𝐾𝐾𝑆𝑆 at different chamber pressures over the vial batch were calculated based 
on the normal distributions of 𝐴𝐴𝑐𝑐 and 𝑙𝑙𝐵𝐵𝑆𝑆, as previously proposed by Scutellà et al.[6]  
 Edge vial effect: It is well known that vials located at the periphery of the shelf receive an 
additional heat transfer by radiation from the wall and the rail and conduction through the 
gas between the chamber wall, the rail and the side wall of the vials. This phenomenon is 
known as edge vial effect. In the present study, the additional radiation heat flow rates from 
the wall and rail to the edge vials were calculated for edge vials using the Stefan-Boltzmann 
equation, as proposed in the 3D simplified radiation model developed by Scutellà et al. [10] 
 Mass transfer resistance: The product resistance variability in a large batch of vials was 
previously quantified as normal distributions of 𝑅𝑅𝑝𝑝0 and 𝑅𝑅𝑝𝑝1 in Scutellà et al.[7] 
 Desorption kinetics: The variability of the desorption kinetics was previously quantified 
as normal distributions of characteristics desorption times in Scutellà et al. [11] 
 
2.3. Prediction of the risk of vial rejection 
The developed mathematical model was used to propose a quality risk-based approach for 
the design of the primary and secondary drying steps of the freeze-drying process. The risk 
of failure of the primary drying step was calculated in terms of vials potentially rejected by 
considering two main constraints: (i) the product temperature had to be maintained at any 
time below a critical value (i.e., the glass transition temperature for amorphous products); (ii) 
the sublimation had to be completed at the end of primary drying (i.e., 𝑓𝑓 = 0). For the design 
of the secondary drying step, the constraints were: (i) the final moisture content had to be 
equal or lower than the target moisture content (1.5 %) and (ii) the temperature at any moment 
had to be lower than the glass transition temperature of the dry product. The range of 
acceptable combinations of operating variables (i.e., 𝑇𝑇𝑠𝑠,  𝑃𝑃𝐶𝐶 , operating time) was then 
identified based on the target level of risk. The capability of the pilot freeze-dryer was 
considered to be not limiting regardless of the operating conditions. 
 
2.4. Numerical solution 
The developed model was solved using Matlab R2014b software provided of the Statistics 
Toolbox (The MathWorks, Inc., Natick, MA). The analysis of the effect of the heat and mass 
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transfer variability on the critical process parameters during freeze-drying was performed 
using the Monte Carlo method. This method consisted in simulation of batches of 100 
representative vials with random normal distributions of the considered model parameters 
(𝐴𝐴𝐶𝐶 ,𝑙𝑙𝐵𝐵𝑆𝑆, 𝑅𝑅𝑝𝑝0, 𝑅𝑅𝑝𝑝1, 𝜏𝜏𝑟𝑟𝑑𝑑𝑑𝑑1 and 𝜏𝜏𝑟𝑟𝑑𝑑𝑑𝑑2). Due to computer limitations, the number of simulated 
vials (100) was significantly smaller than the actual number of vials in the freeze-dryer 
(2310).  
3. Simulated system 
In the present work, the model was used to simulate freeze-drying process performed in the 
pilot freeze-dryer REVO (Millrock Technology, Kingston, United States). The equipment 
was composed of a drying chamber equipped with three shelves and a condenser running at 
temperature of -75 °C. A total of 770 glass tubing vials (Müller + Müller, Holzminden, 
Germany) were supposed to be loaded on each shelf. The vials had a total volume of 3 mL 
and were all filled with 1.8 mL of 5 % aqueous sucrose solution. Furthermore, the vial array 
was surrounded by a metallic rail (shielding 70 % of the lateral wall of the vials). The shelf 
was considered to be at a temperature of -50 °C at the beginning of primary drying.  
4. Results 
The developed model was used to predict the risk of failure of the process in terms of 
percentage of vials potentially rejected. Potential vial rejection of the primary and secondary 
drying steps were predicted for different combinations of operating variables (shelf 
temperature, chamber pressure, operating time) to select the best cycle at the maximum 
allowed risk (1 %). Figure 1A presents the percentage of vial rejection due to a product 
temperature higher than 𝑇𝑇𝑔𝑔′ observed performing a primary drying of 84 hours in function of 
the chamber pressure and shelf temperature. Typical ranges of chamber pressure and shelf 
temperature used in the pharmaceutical industry were explored, respectively between 4 and 
10 Pa, and -40 °C and -10 °C. The results shows that, if a value of shelf temperature higher 
than -27 °C is applied during primary drying, the percentage of vial rejection become higher 
than 1 % for most of the pressures tested. Furthermore, Figure 1B presents the percentage of 
vial rejection due to the sublimation not completed at the end of primary drying observed 
performing a primary drying step of 84 hours in function of the shelf temperature and 
chamber pressure. A shelf temperature higher than -30 °C has to be considered to avoid the 
presence of ice at the end of the primary drying time. Thus, the use of a shelf temperature of 
-27 °C and a chamber pressure between 4 and 9.3 Pa during primary drying step of 84 h 
results in a percentage of vial rejection lower than the maximum allowed one (1 %). Figure 
2A presents the risk of vial rejection associated to the secondary drying step due to a product 
temperature higher than 𝑇𝑇𝑔𝑔. A range of shelf temperatures between 0 °C and 40 °C was 
explored, and the pressure was maintained constant at 6 Pa. The product temperature remains 
below the critical value regardless of the shelf temperature applied during the secondary 
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drying step, because the product dries enough during the shelf temperature ramp (1°C min-
1). Figure 2B presents the risk of vial rejection of associated to the secondary drying step due 
to a final moisture content in the product higher than the target value of 1.5 %. A shelf 
temperature higher than 4 °C will lead to no vial rejection if secondary drying is carried for 
at least 45 h. As product temperature remains below the critical value regardless the shelf 
temperature value used, the optimal operating conditions for secondary drying will be a shelf 
temperature of 40 °C and an operating time of 4 h, which leads to a vials rejection lower than 
1 %. 
 
Fig. 1 Potential vial rejection (%) in primary drying performed at different chamber pressures 
and shelf temperatures due to (A) a product temperature higher than the critical value (𝑻𝑻𝒈𝒈’ ) and 
(B) sublimation not completed after 84 h of primary drying. 
 
 
Fig. 2 Potential vial rejection (%) in secondary drying due to (A) a product temperature higher 
than the critical value (𝑻𝑻𝒈𝒈) during the whole duration of the secondary drying step and (B) 
product moisture content higher than the target value (1.5 %) for different shelf temperatures 
and operating times. 
 
5. Conclusions and perspectives 
In this work, a multi-vial, dynamic mathematical model of the primary and secondary drying 
steps of the freeze-drying process was developed, including the heterogeneity of parameters 
such as the vial dimensions, the vial position on the shelf and the random nucleation process. 
The model was used to calculate the risk of failure of the primary and secondary drying steps 
for a 5 % sucrose solution processed in a pilot freeze-dryer, expressed in terms of percentage 
of vials potentially rejected. In the future, the proposed model will be experimentally 
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validated and used to calculate the design spaces of primary and secondary drying for the 
cycle transfer and scale-up of the process. 
 
Nomenclature 
𝐴𝐴 Cross sectional area (𝑚𝑚²) 
𝐶𝐶1,𝐶𝐶2 Parameters of Equation 3 (𝑊𝑊 𝑚𝑚−4𝐾𝐾−1), (𝑊𝑊 𝑚𝑚−2𝐾𝐾−1 𝑃𝑃𝑎𝑎−1) 
𝐶𝐶𝑝𝑝 Heat capacity (𝐽𝐽 𝐾𝐾−1) 
𝛥𝛥𝐻𝐻 Latent heat (𝐽𝐽 𝑘𝑘𝑘𝑘−1) 
𝑓𝑓 Mass fraction of ice in the product 
𝐾𝐾 Heat transfer coefficient (𝑊𝑊 𝑚𝑚−2𝐾𝐾−1) 
𝑙𝑙 Layer thickness (𝑚𝑚) 
?̇?𝑚 Water vapour flow rate (𝑘𝑘𝑘𝑘 𝑠𝑠−1) 
𝑚𝑚 Mass (𝑘𝑘𝑘𝑘) 
𝑀𝑀𝑊𝑊 Molecular mass of water (𝑘𝑘 𝑚𝑚𝑚𝑚𝑙𝑙−1) 
𝑁𝑁 Number of vials 
𝑃𝑃 Pressure (𝑃𝑃𝑎𝑎) 
?̇?𝑄 Heat flow rate (𝑊𝑊) 
𝑅𝑅𝑔𝑔 Ideal gas constant (𝐽𝐽 𝐾𝐾−1𝑘𝑘𝑚𝑚𝑚𝑚𝑙𝑙−1) 
𝑅𝑅𝑝𝑝 Product resistance (𝑃𝑃𝑎𝑎 𝑚𝑚² 𝑠𝑠 𝑘𝑘𝑘𝑘−1) 
𝑅𝑅𝑝𝑝0,𝑅𝑅𝑝𝑝1 Parameter of Equation 5  (𝑃𝑃𝑎𝑎 𝑚𝑚2𝑠𝑠 𝑘𝑘𝑘𝑘−1), (𝑃𝑃𝑎𝑎 𝑚𝑚 𝑠𝑠 𝑘𝑘𝑘𝑘−1) 
𝑡𝑡 Time (𝑠𝑠) 
𝑇𝑇 Temperature (𝐾𝐾) 
𝑉𝑉 Volume (𝑚𝑚3) 
Greek 
𝛽𝛽 Mass transfer parameter (𝑠𝑠 𝑘𝑘𝑘𝑘−1 𝐾𝐾−1) 
𝜆𝜆 Thermal conductivity (𝑊𝑊 𝑚𝑚−1 𝐾𝐾−1) 
𝜏𝜏𝑟𝑟𝑑𝑑𝑑𝑑 Characteristic desorption time at reference temperature (𝑠𝑠) 
Subscripts and Superscript 
              0 Initial 
𝐵𝐵 Bottom 
𝐶𝐶, 𝑐𝑐 Chamber and contact, respectively 
𝐶𝐶𝑁𝑁 Condenser 
𝑑𝑑 Dried 
𝑑𝑑𝑑𝑑𝑠𝑠 Desorption 
𝑓𝑓 Frozen 
𝑖𝑖 Interface 
𝑖𝑖𝑐𝑐𝑑𝑑 Ice  
𝑃𝑃 Product 
𝑟𝑟 Radiation 
𝑆𝑆, 𝑠𝑠 Shelf and solids, respectively 
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𝑠𝑠𝑠𝑠𝑠𝑠 Sublimation 
𝑇𝑇 Top 
𝑉𝑉, 𝑣𝑣 Vial and vapour, respectively 
𝑤𝑤 Water 
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